Helping veterans with HIV quit smoking
Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV
This study is testing a new program called WISH that helps veterans with HIV quit smoking and improve their overall health using friendly text and voice messages on their phones, making it easy and supportive for everyone, no matter where they are in their quitting journey.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Seattle Inst for Biomedical/clinical Res NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10923803 on NIH RePORTER |
What this research studies
This research focuses on developing a tailored smoking cessation program specifically for veterans living with HIV. The program, called WISH, utilizes mobile phone technology to deliver support through voice and text messages, making it accessible and engaging. It addresses not only smoking cessation but also other health behaviors that are important for overall wellness, such as treatment adherence and stress management. The approach is designed to motivate participants, regardless of their readiness to quit smoking, by enhancing their confidence and skills.
Who could benefit from this research
Good fit: Ideal candidates for this research are veterans who are living with HIV and currently smoke or are interested in quitting smoking.
Not a fit: Patients who do not smoke or are not living with HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the health and quality of life for veterans living with HIV by helping them quit smoking.
How similar studies have performed: Previous research has shown success in using mobile technology for smoking cessation, particularly among specific populations, indicating that this approach has potential.
Where this research is happening
Seattle, United States
- Seattle Inst for Biomedical/clinical Res — Seattle, United States (Active)
Researchers
- Principal investigator: Crothers, Kristina Anne — Seattle Inst for Biomedical/clinical Res
- Study coordinator: Crothers, Kristina Anne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.